5% Tavilermide ophthalmic solution: Clinical Trials

1 trial of 5% Tavilermide ophthalmic solution, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow 5% Tavilermide ophthalmic solution: new trials by email Literature Review of 5% Tavilermide ophthalmic solution trials Research Report on 5% Tavilermide ophthalmic solution

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
5% Tavilermide ophthalmic solution, Vehicle ophthalmic solution - Dry Eye Syndromes, Dry Eye Disease
Phase 3CompletedMimetogen Pharmaceuticals USA, Inc.6422023-06-282024-06-10

Conditions studied

Dry Eye Syndromes (1)

Sponsors

Mimetogen Pharmaceuticals USA, Inc. (1)

Countries

United States (1)